Canis ISSN: 2398-2942

Therapeutics: allergy management

Synonym(s): Canine atopic dermatitis (CAD); Cutaneous adverse food reactions

Contributor(s): Didier Carlotti, Alison Diesel, Rosanna Marsella, Charlie Walker

Threshold of pruritus

  • A given individual can tolerate a variety of stimuli without developing clinical signs as long as the threshold is not reached.
  • All these stimuli have an additive effect and once the threshold is reached itching occurs.
  • Pruritic threshold varies from individual to individual and can be lowered by stress.
  • Allergic dogs often present with combination of allergies and secondary microbial dysbiosis and skin infections, eg Malassezia dermatitis and superficial pyoderma.
  • Hypersensitivity to the associated microflora, such as Malassezia, is a proven further confounding issue.
  • A percentage of dogs with environmental allergies may also have a component of dietary intolerance contributing to their pruritus.
  • Identification and control of concurrent allergies and secondary infections is crucial in the management of dogs with chronic allergies.

Principles of therapy

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Treatment of acute flares of canine AD

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Treatment of chronic canine AD

This article is available in full to registered subscribers

Sign up now to purchase a 30 day trial, or Login

Further Reading

Publications

Refereed papers

  • Recent references from PubMed and VetMedResource.
  • Olivry T, Banovic F (2019) Treatment of canine atopic dermatitis: time to revise our strategy? Vet Dermatol 30, 87-90 PubMed
  • Souza C P, Rosychuk R A W, Contrera E T, Schissler J R, Simpson A C (2018) A retrospective analysis of the use iof lokivetmeb in the management of allergic pruritus in a referral population of 135 dogs in the western USA. Vet Dermatol 29, 489- e164 PubMed.
  • Little P R, King V L, Davis K R, Cosgrove S B, Stegemann M R (2015) A blinded, randomized clinical trial comparing the efficacy and safety of oclacitinib and ciclosporin for the control of atopic dermatitis in client-owned dogs. Vet Dermatol 26, 23-30; e7-8 PubMed
  • Noli C, della Valle M F, Miolo A, Medori C, Schievano C (The Skinalia Clinical Research Group) (2015) Efficacy of ultra-micronized palmitoylethanolamide in canine atopic dermatitis: an open-label multi-centre study. Vet Dermatol 26, 432-e101 PubMed.  
  • Olivry T, De Boer D J, Favrot C, Jackson H, Mueller R S, Nuttall T, Prelaud P (2015) Treatment of canine atopic dermatitis: 2015 updated guideline from the International Committee on Allergic Diseases of Animals (ICADA). BMC Vet Res 11, 210 PubMed
  • Olivry T, Mueller R S, Prélaud P (2015) Critically appraised topic on adverse food reactions of companion animals (1): duration of elimination diets. BMC Vet Res 11, 225 PubMed
  • Gadeyne C, Little P, King V L, Edwards N, Davis K, Stegemann M R (2014) Efficacy of oclacitinib (Apoquel®) compared with prednisolone for the control of pruritus and clinical signs associated with allergic dermatitis in client-owned dogs in Australia. Vet Dermatol 25, 512-518. e86 PubMed
  • Hardy J I, Hendricks A, Loeffler A, Chang Y M, Verheyen K L, Garden O A et al (2014) Foodspecific serum IgE and IgG reactivity in dogs with and without skin disease: lack of correlation between laboratories. Vet Dermatol 25, 447-e70 PubMed
  • Hibberson C E, Vogelnest L J (2014) Storage mite contamination of commercial dry dog food in south-eastern Australia. Aust Vet J 92, 219-224 PubMed
  • Hillier A, Lloyd D H, Weese J S, Blondeau J M, Boothe D, Breitschwerdt E et al (2014) Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases).Vet Dermatol 25, 163-175 e42-3 PubMed
  • Hobi S, Mueller R S (2014) Efficacy and safety of rush immunotherapy with alumprecipitated allergens in canine atopic dermatitis. Tierarztl Prax Ausg K Kleintiere Heimtiere 42, 167-173 PubMed
  • Litzlbauer P, Weber K, Mueller R S (2014) Oral and subcutaneous therapy of canine atopic dermatitis with recombinant feline interferon omega. Cytokine 66, 54-59 PubMed
  • Maina E, Galzerano M, Noli C (2014) Perianal pruritus in dogs with skin disease. Vet Dermatol 25, 204-209; e51–2 PubMed
  • Beco L, Guaguere E, Lorente Mendez C, Noli C, Nuttall T, Vroom M (2013) Suggested guidelines for using systemic antimicrobials in bacterial skin infections: part 2— antimicrobial choice, treatment regimens and compliance. Vet Rec 172, 156-160 PubMed
  • Carlotti D N, Gribeauval C, Costargent F A, Ganiayre J, Viaud S E (2013) A retrospective survey of the results of allergen-specific immunotherapy in 205 atopic dogs in Aquitaine, France (1989–2001). Prat Méd Chir Anim Comp 48, 41-47. 
  • Cosgrove S B, Wren J A, Cleaver D M, Martin D D, Walsh K F, Harfst J A et al (2013) Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis. Vet Dermatol 24, 479-e114 PubMed
  • Cosgrove S B, Wren J A, Cleaver D M, Walsh K F, Follis S I, King V I et al (2013) A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel(R)) in client-owned dogs with atopic dermatitis. Vet Dermatol 24, 587-597. e141-142 PubMed
  • Dip R, Carmichael J, Letellier I, Strehlau G, Roberts E, Bensignor E et al (2013) Concurrent short-term use of prednisolone with cyclosporine A accelerates pruritus reduction and improvement in clinical scoring in dogs with atopic dermatitis. BMC Vet Res 9, 173 PubMed
  • Marsella R, Genovese D, Gilmer L, Ahrens K, Gatto H, Navarro C (2013) Investigations on the effects of a topical ceramides-containing emulsion (Allerderm Spot-on®) on clinical signs and skin barrier function in dogs with atopic dermatitis: a doubleblinded randomized controlled study. Intern J Appl Res Vet Med 11, 110-116. 
  • Berger D J, Lewis T P, Schick A E, Stone R T (2012) Comparison of once-daily versus twiceweekly terbinafine administration for the treatment of canine Malassezia dermatitis-a pilot study. Vet Dermatol 23, 418-e79 PubMed
  • Bethlehem S, Bexley J, Mueller R S (2012) Patch testing and allergen-specific serum IgE and IgG antibodies in the diagnosis of canine adverse food reactions. Vet Immunol Immunopathol 145, 582-589 PubMed
  • DeBoer D J, Morris M (2012) Multicentre open trial demonstrates efficacy of sublingual immunotherapy in canine atopic dermatitis. Vet Dermatol 23 Suppl 1:65 (abstract).
  • Lourenço-Martins A M, São-Braz B, Schmidt V, Rème C A, Nuttall T J (2012) Long-term maintenance therapy of canine atopic dermatitis with a 0.0584 % hydrocortisone aceponate spray (Cortavance) used on two consecutive days each week. Vet Dermatol 23, Suppl 1:39 (abstract).
  • Nam E H, Park S H, Jung J Y, Han S H, Young H Y, Chae J S et al (2012) Evaluation of the effect of a 0.0584 % hydrocortisone aceponate spray on clinical signs and skin barrier function in dogs with atopic dermatitis. J Vet Sci 13, 187-191 PubMed
  • Nuttall T J, McEwan N A, Bensignor E, Cornegliani L, Lowenstein C, Reme C A (2012) Comparable efficacy of a topical 0.0584 % hydrocortisone aceponate spray and oral ciclosporin in treating canine atopic dermatitis. Vet Dermatol 23, 4-10; e1-2 PubMed
  • Cadot P, Hensel P, Bensignor E, Hadjaje C, Marignac G, Beco L et al (2011) Masitinib decreases signs of canine atopic dermatitis: a multicentre, randomized, doubleblind, placebo-controlled phase 3 trial. Vet Dermatol 22, 554-564 PubMed
  • Gill C, McEwan N, McGarry J, Nuttall T (2011) House dust and storage mite contamination of dry dog food stored in open bags and sealed boxes in 10 domestic households. Vet Dermatol 22, 162-172 PubMed
  • Popa I, Pin D, Remoue N, Osta B, Callejon S, Videmont E et al (2011) Analysis of epidermal lipids in normal and atopic dogs, before and after administration of an oral omega-6/omega-3 fatty acid feed supplement. A pilot study. Vet Res Commun 35, 501–509 PubMed
  • DeBoer D, Verbrugge M, Morris M (2010) Clinical and serological response of dust mitesensitive dogs with atopic dermatitis to sublingual immunotherapy. Allergo J 19, 317 (abstract).
  • Taszkun I (2010) The evaluation of Canine Atopic Dermatitis Extent and Severity Index (CADESI) test in dogs with atopic dermatitis (AD) treated with cyclosporine or prednisone. Pol J Vet Sci 13, 681-688 PubMed.
  • Olivry T, DeBoer D J, Prélaud P, Bensignor E (2007) Food for thought: pondering the relationship between canine atopic dermatitis and cutaneous adverse food reactions. Vet Dermatol 18, 390 PubMed
  • Steffan J, Favrot C, Mueller R (2006) A systematic review and meta-analysis of the efficacy and safety of cyclosporin for the treatment of atopic dermatitis in dogs. Vet Dermatol 17, 3-16  PubMed.
  • Farver K, Morris D O, Schofer F, Esch B (2005) Humoral measurement of type-1 hypersensitivity reactions to a commercial Malassezia allergen. Vet Dermatol 16 (4), 261-268 PubMed
  • Bensignor E & Olivry T, (2005) Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded, randomized, controlled trial. Vet Dermatol 16, 52-60 PubMed
  • Swinnen C, Vroom M (2004) The clinical effect of environmental control of house dust mites in 60 house dust mite-sensitive dogs. Vet Dermatol 15, 31-36 PubMed.
  • Pinchbeck L R, Hillier A, Kowalski J J, Kwochka K W (2002) Comparison of pulse administration versus once daily administration of itraconazole for the treatment of Malassezia pachydermatis dermatitis and otitis in dogs. J Am Vet Med Assoc 220, 1807-1812 PubMed.   


ADDED